Expiratory gas analysis using mass spectrometry in chronic obstructive pulmonary disease

N. Kawata (Chiba, Japan), T. Sugiura (Chiba, Japan), Y. Matsuura (Chiba, Japan), J. Ikari (Chiba, Japan), E. Suzuki (Chiba, Japan), M. Abe (Chiba, Japan), Y. Tada (Chiba, Japan), N. Sakurai (kisarazuChiba, Japan), K. Tatsumi (Chiba, Japan)

Source: International Congress 2019 – Research and innovation in airway diseases
Session: Research and innovation in airway diseases
Session type: Thematic Poster
Number: 4276
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kawata (Chiba, Japan), T. Sugiura (Chiba, Japan), Y. Matsuura (Chiba, Japan), J. Ikari (Chiba, Japan), E. Suzuki (Chiba, Japan), M. Abe (Chiba, Japan), Y. Tada (Chiba, Japan), N. Sakurai (kisarazuChiba, Japan), K. Tatsumi (Chiba, Japan). Expiratory gas analysis using mass spectrometry in chronic obstructive pulmonary disease. 4276

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013


Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Expiratory flow limitation during ELTGOL in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 287s
Year: 2006

Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011


Fat free mass and exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


Respiratory muscle training in patients with stable chronic obstructive pulmonary disease: Its effect on hyperinflation and gas trapping
Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease
Year: 2010

Gas exchange impairment in COPD with severe pulmonary hypertension
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Change in muscle mass in training patients with chronical obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Inspiratory flow rates in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 255s
Year: 2002

Maximal inspiratory pressure and BODE index in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training
Year: 2010


Non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension with ventilatory gas analysis
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016

The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight
Source: Eur Respir J 2005; 26: Suppl. 49, 698s
Year: 2005

Modeling of oxygen uptake kinetics during exercise testing in patients with chronic obstructive pulmonary diseases (COPD)
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Determining why patients with idiopathic pulmonary fibrosis (IPF) have difficulty performing gas transfer
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013


Dynamic hyperinflation during 6MWT in stable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Year: 2007


Influence of body mass index in exercise capacity in patients with chronic obstructive pulmonary disease under pulmonary rehabilitation
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017

Body composition and pulmonary function in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 626s
Year: 2006